Arteris (NASDAQ:AIP) CEO Sells $17,957.61 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 2,057 shares of the firm’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $8.73, for a total transaction of $17,957.61. Following the completion of the transaction, the chief executive officer directly owned 186,482 shares of the company’s stock, valued at approximately $1,627,987.86. This trade represents a 1.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

K Charles Janac also recently made the following trade(s):

• On Tuesday, September 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The shares were sold at an average price of $8.94, for a total transaction of $11,139.24.
• On Tuesday, August 5th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total transaction of $656,000.00.
• On Tuesday, August 5th, K Charles Janac sold 94,245 shares of Arteris stock. The shares were sold at an average price of $13.49, for a total transaction of $1,271,365.05.
• On Thursday, July 3rd, K Charles Janac sold 11,815 shares of Arteris stock. The shares were sold at an average price of $9.25, for a total transaction of $109,288.75.
• On Wednesday, July 2nd, K Charles Janac sold 7,153 shares of Arteris stock. The shares were sold at an average price of $8.99, for a total transaction of $64,305.47.
• On Tuesday, July 1st, K Charles Janac sold 2,666 shares of Arteris stock. The stock was sold at an average price of $9.09, for a total transaction of $24,233.94.
• On Friday, June 27th, K Charles Janac sold 18,620 shares of Arteris stock. The stock was sold at an average price of $10.02, for a total transaction of $186,572.40.

Arteris Stock Up 1.5%

NASDAQ AIP opened at $8.72 on Wednesday. The company has a fifty day moving average of $9.50 and a two-hundred day moving average of $8.22. The firm has a market capitalization of $371.91 million, a price-to-earnings ratio of -10.63 and a beta of 1.44. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.29.

Arteris (NASDAQ:AIP) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Wall Street Zen lowered shares of Arteris from a “hold” rating to a “sell” rating in a research note on Sunday. TD Cowen boosted their target price on shares of Arteris from $12.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Arteris currently has a consensus rating of “Buy” and an average price target of $15.00.

Institutional Trading of Arteris

Large investors have recently made changes to their positions in the stock. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris during the first quarter valued at $95,000. Two Sigma Advisers LP boosted its stake in shares of Arteris by 82.9% during the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock valued at $240,000 after purchasing an additional 10,700 shares during the period. BNP Paribas Financial Markets bought a new stake in shares of Arteris in the fourth quarter valued at about $214,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Arteris in the fourth quarter valued at about $117,000. Finally, Northern Trust Corp raised its holdings in shares of Arteris by 6.6% in the fourth quarter. Northern Trust Corp now owns 224,443 shares of the company’s stock valued at $2,287,000 after acquiring an additional 13,838 shares in the last quarter. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.